Medsafe

All indigestion medicines containing ranitidine have been recalled or had their supply halted after a carcinogenic impurity was identified in it

Two pharmaceutical companies have voluntarily recalled the ranitidine-containing indigestion medication Zantac after a potentially carcinogenic impurity was identified in it last month

Emotions ran high at the Health Select Committee yesterday, with MPs grilling Medsafe and the Ministry of Health on a brand change to a generic antidepressant

Medsafe appears to have got its skates on when it comes to progressing pharmacy licence applications

Pharmacy Today reporter Angela Woods chats to Chris James, the man at the helm of Medsafe, which instigated the sometimes unpopular surprise audits

Audit performance is continuing to improve, Medsafe’s latest figures show, but full compliance remains below 50 per cent

Medsafe has issued a warning about weight-loss products found to contain two prescription medicines withdrawn over safety concerns

Medsafe has opened a public consultation on plans to introduce new labelling requirements for non-active substances in medicines (exipients) which may cause a bad reaction, eg: allergies.

Since it was first piloted in Auckland in 2017, Medsafe’s new unannounced pharmacy auditing programme has been a bone of contention for pharmacists